Brief: Xortx Therapeutics Appoints Dave Matthews CFO
22/02/2018 12:30
Feb 22 (Reuters) - Xortx Therapeutics Inc XRX.CD :
* XORTX THERAPEUTICS APPOINTS DAVE MATTHEWS CFO
Source text for Eikon: ID:nGNX4MwKGM
Further company coverage: XRX.CD
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering
Brief: Xortx Announces Closing Of Acquisition Of Vectus Kidney Anti-Fibrotic Asset
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM